Mansur Aliyu

Mansur Aliyu

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 April 2024 in Immunopharmacology and Immunotoxicology
Verified
Journal Article
Closed access
MAMansur Aliyu
Mansur Aliyu
FZFatema Tuz Zohora
Fatema Tuz Zohora
ACAyca Ceylan
Ayca Ceylan
FHFariha Hossain
Fariha Hossain
RYReza Yazdani
Reza Yazdani
GAGholamreza Azizi
Gholamreza Azizi
Background: Multiple sclerosis (MS) is a central nervous system (CNS) demyelinating autoimmune disease with increasing global prevalence. It predominantly affects females, especially those of European descent. The interplay between environmental factors and genetic predisposition plays a crucial role in MS etiopathogenesis. Methods: We search recent relevant literature on reputable databases, which include, PubMed, Embase, Web of Science, Scopus, ScienceGirect using the following keywords: multiple sclerosis, pathogenesis, autoimmunity, demyelination, therapy, immunotherapy. Results: Various animal models have been utilized to study MS etiopathogenesis and therapeutics. Autoreative T cells within the CNS recruit myeloid cells through chemokine expression, leading to the secretion of inflammatory cytokines driving the MS pathogenesis, resulting in demyelination, gliosis, and axonal loss. Key players include T cell lymphocytes (CD4+ and CD8+), microbiota B cells, and neutrophils. Signaling dysregulation in inflammation pathways and the immunogenetic basis of MS are essential considerations. The pathogenesis of MS involves demyelination, gliosis, and axonal loss driven by inflammatory cytokines. While T cells are traditionally recognized as central to MS, evidence suggests a significant role for B cells and neutrophils. High neutrophil-to-lymphocyte ratios correlate with MS severity, indicating their contribution to disease progression. Dysregulated signaling pathways further exacerbate MS progression. Conclusion: MS remains incurable, but disease-modifying therapies, monoclonal antibodies, and immunomodulatory drugs offer hope for patients. Ongoing research into the immunogenetics and immunoregulatory roles of gut microbiota continues to shed light on potential therapeutic avenues. Understanding the complex interplay between genetic predisposition, environmental factors, and immune dysregulation is critical for developing effective treatments for MS.

8 July 2023 in Heliyon
Verified
Journal Article
Open access
FZFatema Tuz Zohora
Fatema Tuz Zohora
MAMansur Aliyu
Mansur Aliyu
ASAli Akbar Saboor-Yaraghi
Ali Akbar Saboor-Yaraghi
The bone marrow (BM) plays a pivotal role in homeostasis by supporting hematopoiesis and immune cells' activation, maturation, interaction, and deployment. “BMSC-derived secretome” refers to the complete repertoire of secreted molecules, including nucleic acids, chemokines, growth factors, cytokines, and lipids from BM-derived mesenchymal stem cells (BMSCs). BMSC-derived secretomes are the current molecular platform for acellular therapy. Secretomes are highly manipulable and can be synthesised in vast quantities using commercially accessible cell lines in the laboratory. Secretomes are less likely to elicit an immunological response because they contain fewer surface proteins. Moreover, the delivery of BMSC-derived secretomes has been shown in numerous studies to be an effective, cell-free therapy method for alleviating the symptoms of inflammatory and degenerative diseases. As a result, secretome delivery from BMSCs has the same therapeutic effects as BMSCs transplantation but may have fewer adverse effects. Additionally, BMSCs’ secretome has therapeutic promise for organoids and parabiosis studies. This review focuses on recent advances in secretome-based cell-free therapy, including its manipulation, isolation, characterisation, and delivery systems. The diverse bioactive molecules of secretomes that successfully treat inflammatory and degenerative diseases of the musculoskeletal, cardiovascular, nervous, respiratory, reproductive, gastrointestinal, and anti-ageing systems were also examined in this review. However, secretome-based therapy has some unfavourable side effects that may restrict its uses. Some of the adverse effects of this modal therapy were briefly mentioned in this review.

1 September 2021 in Journal of Medical Mycology
Verified
Journal Article
Closed access
MGMuhammad Ibrahim Getso
Muhammad Ibrahim Getso
SHSeyed-Jamal Hashemi
Seyed-Jamal Hashemi
RGRoshanak Daie Ghazvini
Roshanak Daie Ghazvini
SYShehu Mohammed Yusuf
Shehu Mohammed Yusuf
SKSadegh Khodavaisy
Sadegh Khodavaisy
MAMansur Aliyu
Mansur Aliyu

23 March 2021 in Biochemical Genetics
Verified
Journal Article
Closed access
PDF file
DIDanyal Imani
Danyal Imani
NDNavid Dashti
Navid Dashti
APArash Parvari
Arash Parvari
SSSajad Shafiekhani
Sajad Shafiekhani
FAFatemeh Alebrahim
Fatemeh Alebrahim
MAMansur Aliyu
Mansur Aliyu

9 January 2025 in Critical Reviews in Oncology/Hematology
Verified
Journal Article
Closed access
BABilkisu Ahmed
Bilkisu Ahmed
MAMansur Aliyu
Mansur Aliyu
MGMuhammad Ibrahim Getso
Muhammad Ibrahim Getso
JBJamilu Abubakar Bala
Jamilu Abubakar Bala
RARamat Jummai Ahmed
Ramat Jummai Ahmed
AYAminu Abba Yusuf
Aminu Abba Yusuf

30 December 2021 in UMYU Journal of Microbiology Research (UJMR)
Verified
Journal Article
Open access
KHK. M. Hamid
K. M. Hamid
AYA. Yakubu
A. Yakubu
SSS. A. Sani
S. A. Sani
MKM. U. Kalgo
M. U. Kalgo
AIA. Isiyaku
A. Isiyaku
UAUsman Abubakar
Usman Abubakar
The study evaluates the potential immunocytotoxic effect of aqueous leaf extract of Cassia occidentalis on human peripheral blood mononuclear cells (PBMCs) and Neutrophils. Different concentrations (25 µg/ml, 50 µg/ml, 100 µg/ml) of the extract were prepared. Six millilitres (6ml) of peripheral blood from consented healthy volunteers was collected and PBMCs and neutrophils were isolated on Histopaque media. The viability of PBMCs and neutrophils was determined using trypan blue dye exclusion methods. One-way analysis of variance was used in analysing the results. Total viable cell count (TVCC) for PBMCs and neutrophils yielded 298.9 x 10^4 cells/ml and 327.9 x 10^4 cells/ml respectively. The TVCC of the highest concentration (100 µg/ml) of the extract used for the treatment of PBMCs was 192.7 x 10^4 cells/ml and that of neutrophil was 50.47 x 10^4 cells/ml equivalent to 82.51% and 61.71% mean viability percentages respectively. The PBMCs and neutrophils treated with 25 µg/ml of the extract have the highest mean percentage viability scores of 94.88% and 74.61% respectively. There was a significant difference in the mean percentage viability when control PBMCs was compared with those treated with 100 µg/ml (p<0.0001) and also when control neutrophils was compared with those treated with 25 µg/ml (p=0.02), 50 µg/ml and 100 µg/ml (p<0.0001) respectively. The cell viability tends to decrease in a dose-dependent manner. The aqueous leaf extract of C. occidentalis has a potent cytotoxic effect on both cells, especially at a higher dose. The study recommends an in-depth study to improve the credence of the present study findings.